Radiomics in esophageal and gastric cancer.

Abdom Radiol (NY)

Department of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.

Published: June 2019

Esophageal, esophago-gastric, and gastric cancers are major causes of cancer morbidity and cancer death. For patients with potentially resectable disease, multi-modality treatment is recommended as it provides the best chance of survival. However, quality of life may be adversely affected by therapy, and with a wide variation in outcome despite multi-modality therapy, there is a clear need to improve patient stratification. Radiomic approaches provide an opportunity to improve tumor phenotyping. In this review we assess the evidence to date and discuss how these approaches could improve outcome in esophageal, esophago-gastric, and gastric cancer.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934409PMC
http://dx.doi.org/10.1007/s00261-018-1724-8DOI Listing

Publication Analysis

Top Keywords

gastric cancer
8
esophageal esophago-gastric
8
esophago-gastric gastric
8
radiomics esophageal
4
esophageal gastric
4
cancer
4
cancer esophageal
4
gastric cancers
4
cancers major
4
major cancer
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!